Memantine vs Osimertinib
Memantine vs Osimertinib: Overview
This comparison examines the pharmacological differences between Memantine and Osimertinib.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Memantine β 60-80 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Memantine β C12H21N; Osimertinib β C28H33N7O2.
Molecular Weight: Memantine β 179.3080 g/mol; Osimertinib β 499.6050 g/mol.
Type: Memantine β Small molecule; Osimertinib β Small molecule.